Global Nitinol-based Interventional Device Market Research Report 2023

Publication ID:

PB510235177

Publication Date:

October 3, 2023

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Nitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc
The global Nitinol-based Interventional Device market is projected to reach US$ 36460 million in 2029, increasing from US$ 21890 million in 2022, with the CAGR of 7.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nitinol-based Interventional Device 91制片厂.
The Nitinol-based Interventional Device market is driven by the growing demand for minimally invasive medical procedures and the unique properties of Nitinol alloy in interventional device design. Nitinol, a shape memory alloy, offers remarkable flexibility, shape retention, and biocompatibility, making it an ideal material for various interventional devices like stents, guidewires, and filters. The rise in chronic diseases, such as cardiovascular conditions and peripheral artery diseases, contributes to market growth as healthcare professionals seek advanced devices that ensure precise placement and effective treatment. Moreover, Nitinol's ability to change shape with temperature variations aligns with improved device deployment and reduced patient discomfort. However, the market also faces challenges, including manufacturing complexities due to the unique properties of Nitinol and the need for rigorous testing to ensure device reliability. Additionally, addressing concerns related to long-term device performance and biocompatibility, and managing potential allergic reactions, can pose obstacles for manufacturers. To succeed, companies must focus on material advancements, precise device engineering, and addressing the challenges to provide safe and efficient Nitinol-based interventional devices that enhance patient outcomes and revolutionize minimally invasive medical procedures.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nitinol-based Interventional Device market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
TERUMO
BD
Stryker
Cook Medical
Cordis
B. Braun
Biotronik
MicroPort
JOTEC
Acandis
ELLA-CS
Segment by Type
Stents
Guidewires
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Nitinol-based Interventional Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Nitinol-based Interventional Device Market Overview
1.1 Product Overview and Scope of Nitinol-based Interventional Device
1.2 Nitinol-based Interventional Device Segment by Type
1.2.1 Global Nitinol-based Interventional Device Market Value Comparison by Type (2023-2029)
1.2.2 Stents
1.2.3 Guidewires
1.2.4 Others
1.3 Nitinol-based Interventional Device Segment by Application
1.3.1 Global Nitinol-based Interventional Device Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Nitinol-based Interventional Device Market Size Estimates and Forecasts
1.4.1 Global Nitinol-based Interventional Device Revenue 2018-2029
1.4.2 Global Nitinol-based Interventional Device Sales 2018-2029
1.4.3 Global Nitinol-based Interventional Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nitinol-based Interventional Device Market Competition by Manufacturers
2.1 Global Nitinol-based Interventional Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nitinol-based Interventional Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nitinol-based Interventional Device Average Price by Manufacturers (2018-2023)
2.4 Global Nitinol-based Interventional Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nitinol-based Interventional Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nitinol-based Interventional Device, Product Type & Application
2.7 Nitinol-based Interventional Device Market Competitive Situation and Trends
2.7.1 Nitinol-based Interventional Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nitinol-based Interventional Device Players Market Share by Revenue
2.7.3 Global Nitinol-based Interventional Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nitinol-based Interventional Device Retrospective Market Scenario by Region
3.1 Global Nitinol-based Interventional Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nitinol-based Interventional Device Global Nitinol-based Interventional Device Sales by Region: 2018-2029
3.2.1 Global Nitinol-based Interventional Device Sales by Region: 2018-2023
3.2.2 Global Nitinol-based Interventional Device Sales by Region: 2024-2029
3.3 Global Nitinol-based Interventional Device Global Nitinol-based Interventional Device Revenue by Region: 2018-2029
3.3.1 Global Nitinol-based Interventional Device Revenue by Region: 2018-2023
3.3.2 Global Nitinol-based Interventional Device Revenue by Region: 2024-2029
3.4 North America Nitinol-based Interventional Device Market Facts & Figures by Country
3.4.1 North America Nitinol-based Interventional Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nitinol-based Interventional Device Sales by Country (2018-2029)
3.4.3 North America Nitinol-based Interventional Device Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nitinol-based Interventional Device Market Facts & Figures by Country
3.5.1 Europe Nitinol-based Interventional Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nitinol-based Interventional Device Sales by Country (2018-2029)
3.5.3 Europe Nitinol-based Interventional Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nitinol-based Interventional Device Market Facts & Figures by Country
3.6.1 Asia Pacific Nitinol-based Interventional Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nitinol-based Interventional Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Nitinol-based Interventional Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nitinol-based Interventional Device Market Facts & Figures by Country
3.7.1 Latin America Nitinol-based Interventional Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nitinol-based Interventional Device Sales by Country (2018-2029)
3.7.3 Latin America Nitinol-based Interventional Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nitinol-based Interventional Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Nitinol-based Interventional Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nitinol-based Interventional Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nitinol-based Interventional Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nitinol-based Interventional Device Sales by Type (2018-2029)
4.1.1 Global Nitinol-based Interventional Device Sales by Type (2018-2023)
4.1.2 Global Nitinol-based Interventional Device Sales by Type (2024-2029)
4.1.3 Global Nitinol-based Interventional Device Sales Market Share by Type (2018-2029)
4.2 Global Nitinol-based Interventional Device Revenue by Type (2018-2029)
4.2.1 Global Nitinol-based Interventional Device Revenue by Type (2018-2023)
4.2.2 Global Nitinol-based Interventional Device Revenue by Type (2024-2029)
4.2.3 Global Nitinol-based Interventional Device Revenue Market Share by Type (2018-2029)
4.3 Global Nitinol-based Interventional Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nitinol-based Interventional Device Sales by Application (2018-2029)
5.1.1 Global Nitinol-based Interventional Device Sales by Application (2018-2023)
5.1.2 Global Nitinol-based Interventional Device Sales by Application (2024-2029)
5.1.3 Global Nitinol-based Interventional Device Sales Market Share by Application (2018-2029)
5.2 Global Nitinol-based Interventional Device Revenue by Application (2018-2029)
5.2.1 Global Nitinol-based Interventional Device Revenue by Application (2018-2023)
5.2.2 Global Nitinol-based Interventional Device Revenue by Application (2024-2029)
5.2.3 Global Nitinol-based Interventional Device Revenue Market Share by Application (2018-2029)
5.3 Global Nitinol-based Interventional Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Nitinol-based Interventional Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Edwards Lifesciences
6.2.1 Edwards Lifesciences Corporation Information
6.2.2 Edwards Lifesciences Description and Business Overview
6.2.3 Edwards Lifesciences Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Edwards Lifesciences Nitinol-based Interventional Device Product Portfolio
6.2.5 Edwards Lifesciences Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medtronic Nitinol-based Interventional Device Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Boston Scientific
6.4.1 Boston Scientific Corporation Information
6.4.2 Boston Scientific Description and Business Overview
6.4.3 Boston Scientific Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boston Scientific Nitinol-based Interventional Device Product Portfolio
6.4.5 Boston Scientific Recent Developments/Updates
6.5 TERUMO
6.5.1 TERUMO Corporation Information
6.5.2 TERUMO Description and Business Overview
6.5.3 TERUMO Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 TERUMO Nitinol-based Interventional Device Product Portfolio
6.5.5 TERUMO Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BD Nitinol-based Interventional Device Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Stryker Nitinol-based Interventional Device Product Portfolio
6.7.5 Stryker Recent Developments/Updates
6.8 Cook Medical
6.8.1 Cook Medical Corporation Information
6.8.2 Cook Medical Description and Business Overview
6.8.3 Cook Medical Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cook Medical Nitinol-based Interventional Device Product Portfolio
6.8.5 Cook Medical Recent Developments/Updates
6.9 Cordis
6.9.1 Cordis Corporation Information
6.9.2 Cordis Description and Business Overview
6.9.3 Cordis Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cordis Nitinol-based Interventional Device Product Portfolio
6.9.5 Cordis Recent Developments/Updates
6.10 B. Braun
6.10.1 B. Braun Corporation Information
6.10.2 B. Braun Description and Business Overview
6.10.3 B. Braun Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.10.4 B. Braun Nitinol-based Interventional Device Product Portfolio
6.10.5 B. Braun Recent Developments/Updates
6.11 Biotronik
6.11.1 Biotronik Corporation Information
6.11.2 Biotronik Nitinol-based Interventional Device Description and Business Overview
6.11.3 Biotronik Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Biotronik Nitinol-based Interventional Device Product Portfolio
6.11.5 Biotronik Recent Developments/Updates
6.12 MicroPort
6.12.1 MicroPort Corporation Information
6.12.2 MicroPort Nitinol-based Interventional Device Description and Business Overview
6.12.3 MicroPort Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.12.4 MicroPort Nitinol-based Interventional Device Product Portfolio
6.12.5 MicroPort Recent Developments/Updates
6.13 JOTEC
6.13.1 JOTEC Corporation Information
6.13.2 JOTEC Nitinol-based Interventional Device Description and Business Overview
6.13.3 JOTEC Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.13.4 JOTEC Nitinol-based Interventional Device Product Portfolio
6.13.5 JOTEC Recent Developments/Updates
6.14 Acandis
6.14.1 Acandis Corporation Information
6.14.2 Acandis Nitinol-based Interventional Device Description and Business Overview
6.14.3 Acandis Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Acandis Nitinol-based Interventional Device Product Portfolio
6.14.5 Acandis Recent Developments/Updates
6.15 ELLA-CS
6.15.1 ELLA-CS Corporation Information
6.15.2 ELLA-CS Nitinol-based Interventional Device Description and Business Overview
6.15.3 ELLA-CS Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2018-2023)
6.15.4 ELLA-CS Nitinol-based Interventional Device Product Portfolio
6.15.5 ELLA-CS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nitinol-based Interventional Device Industry Chain Analysis
7.2 Nitinol-based Interventional Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nitinol-based Interventional Device Production Mode & Process
7.4 Nitinol-based Interventional Device Sales and Marketing
7.4.1 Nitinol-based Interventional Device Sales Channels
7.4.2 Nitinol-based Interventional Device Distributors
7.5 Nitinol-based Interventional Device Customers
8 Nitinol-based Interventional Device Market Dynamics
8.1 Nitinol-based Interventional Device Industry Trends
8.2 Nitinol-based Interventional Device Market Drivers
8.3 Nitinol-based Interventional Device Market Challenges
8.4 Nitinol-based Interventional Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
TERUMO
BD
Stryker
Cook Medical
Cordis
B. Braun
Biotronik
MicroPort
JOTEC
Acandis
ELLA-CS

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.